NEW YORK (GenomeWeb) – WaferGen Biosystems is preparing to sell an undisclosed amount of Class A and Class B units to raise up to $34.5 million in a public offering, according to a document filed with the US Securities and Exchange Commission.

In a Form S-1 filed Aug. 14, the firm said it will offer an undisclosed number of Class A units, consisting of shares of the firm's common stock and warrants to purchase shares of common stock. Each warrant will allow the holder to purchase one share of WaferGen's stock at an exercise price still to be determined.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.